As the coronavirus disease (COVID-19) continues to physically affect millions of people and counting, the run for effective treatments and vaccines is in full swing. More than 350 drugs are under development, destined to be administered to patients by injection. More than two thirds of these drugs for injection are large, complex molecule drugs that demand significant quality requirements of their primary packaging.

Which is where Nipro come in. Nipro PharmaPackaging offers the VIALEX™ technology which mitigates both effects from the converting process on the inner glass surface of vials:

• Reduces the sodium concentration
• Improves the inner glass surface

Click Here to Read The Full Article https://www.nipro-group.com/en/inspire/vialextm-long-term-study-confirms-improved-surface-durability